Emergent BioSolutions Inc. (NYSE: EBS) today announced the appointment of Seamus Mulligan to the company’s Board of Directors effective March 19, 2019. Mr. Mulligan was a co-founder and principal investor of Adapt Pharma Ltd. and served as its chairman and CEO from 2014 until 2018, when Adapt was acquired by Emergent.
{iframe}https://www.streetinsider.com/Corporate+News/Emergent+BioSolutions+%28EBS%29+Appoints+Seamus+Mulligan+to+Board/15111666.html{/iframe}